Irvine, California, 92618, United States
NCT Number: NCT00370747
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male/female at least 18 years of age
- Agree to avoid disallowed medications
- Have a diagnosis of dry eye
Exclusion criteria
- Have chronic systemic inflammation
- Have active seasonal ocular allergies
Treatment and study plan
Ecabet
Drugophthalmic solution 2.83%
Placebo
DrugPrimary outcomes
-
Ocular signs and Symptoms
Time frame: 90 days
ocular signs, including corneal and conjunctival staining, tear film breakup time and blink rate, and ocular symptoms, including burning or stinging, itchiness or scratchiness, grittiness or sandiness, foreign body sensation, haziness or blurriness, photophobia, photopsia, and eye discomfort
Secondary outcomes
-
Ocular Surface Disease Index (OSDI)
Time frame: 90 days
Questionaire
Sponsors and collaborators
Lead sponsor
Bausch & Lomb Incorporated
Industry
Registry information
Official study title
Efficacy and Safety of Ecabet Ophthalmic Solution for the Treatment of Dry Eye Syndrome
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Sep 1, 2006
- Registry last updated
- Mar 15, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome
NCT05481450
Dry Eye, Dry Eye Syndromes
Lutz, Florida, United States
View Trial DetailsPreoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction
NCT06483750
Cataract Senile, Dry Eye Disease
Washington D.C., District of Columbia, United States
View Trial DetailsTolerability Comparison of Flarex to Lotemax SM
NCT07588074
Conjunctival Diseases, Conjunctivitis
Baton Rouge, Louisiana, United States
View Trial DetailsAssessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs
NCT04730336
Dry Eye, Dry Eye Syndromes
Solihull, United Kingdom
View Trial Details